Skip to main content
. Author manuscript; available in PMC: 2014 Jun 16.
Published in final edited form as: Clin Cancer Res. 2011 Jan 11;17(2):346–352. doi: 10.1158/1078-0432.CCR-10-1161

Table 1.

Front-line treatment of PCNSL patients

Treatment Patients no. (%)
Chemotherapy only 18 patients (62%)
Chemo-immunotherapy only 2 patients (7%)
Chemotherapy and WBRT 9 patients (31%)
Surgical resection* 9 patients (31%)
ASCT 2 patients (7%)

Immunotherapy = rituximab.

WBRT = whole brain radiotherapy.

*

These patients had surgical resection prior to definitve treatment.

ASCT = autologous stem cell transplantation